Jefferies Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Jefferies Financial Group's MRNA Position: Q3 2026 in Review
Jefferies Financial Group reduced its Moderna (MRNA) stake by 48% in Q3 2026, selling an estimated $1.27M and leaving 12,920 shares worth $2.49M. The position accounts for 0.02% of the portfolio, ranked #490.
Jefferies Financial Group first reported a position in MRNA in Q2 2023 and has held it in 14 quarters since. The position peaked at $47.3M in Q1 2024. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Jefferies Financial Group held 12,920 shares of Moderna worth $2.49M as of Q3 2026.
- Jefferies Financial Group sold 11,809 Moderna shares in Q3 2026, an estimated $1.27M.
- Moderna made up 0.02% of Jefferies Financial Group's portfolio in Q3 2026, its #490 holding.
- Jefferies Financial Group first reported a position in Moderna in Q2 2023 and has held it in 14 quarters since.
- Jefferies Financial Group's Moderna position peaked at $47.3M in Q1 2024.
- 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.